6295-93-8

Basic information

• Product Name: 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione
• CAS NO: 6295-93-8
• Molecular Formula: C₂₀H₁₄N₂O₂
• Molecular Weight: 314.3374
• Mol File: 6295-93-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 483.8°C at 760 mmHg
• Flash Point: 218.3°C
• Density: 1.351g/cm³
• Vapor Pressure: 1.63E-09mmHg at 25°C
• Refractive Index: 1.714
• CAS DataBase Reference: 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione(6295-93-8)
• EPA Substance Registry System: 2-(diphenylamino)-1H-isoindole-1,3(2H)-dione(6295-93-8)

Safety Data

• Hazardous Substances Data: 6295-93-8(Hazardous Substances Data)

Usage

General Description

2-(diphenylamino)-1H-isoindole-1,3(2H)-dione is a chemical compound with a complex molecular structure. It is a derivative of isoindole-1,3-dione, a nitrogen-containing heterocyclic compound. This chemical has two phenyl groups attached to the amino group, and it is commonly used as a pigment in the manufacturing of dyes and inks. It is also used in the field of organic synthesis and materials science for its unique properties. Additionally, it has potential applications in the medical field due to its ability to inhibit certain enzymes and biological processes.

Upstream product

• 4870-16-0 N-anilinophthalimide 
• 603-33-8 triphenylbismuthane 
• 85-44-9 phthalic anhydride 
• 530-47-2 N,N-diphenylhydrazine hydrochloride 
• 524-38-9 N-hydroxyphthalimide 

Downstream Products

• 32228-99-2 4-phenyldiphenylamine 
• 86-74-8 9H-carbazole 
• 530-50-7 1,1-Diphenylhydrazine 

Relevant articles and documents

INHIBITORS OF IRES-MEDIATED PROTEIN SYNTHESIS

This disclosure relates to inhibitors of IRES-mediated protein synthesis, compositions comprising therapeutically effective amounts of these compounds, and methods of using those compounds and compositions in treating hyperproliferative disorders, e.g., cancers. This disclosure also relates to compositions comprising inhibitors of IRES-mediated protein synthesis and mTOR inhibitors, and to methods of treating cancer by conjoint administration of inhibitors of IRES-mediated protein synthesis and mTOR inhibitors.

N-phenylation of N-arylaminophthalimides with triphenylbismuth and cupric acetate: A convenient synthesis of 1-aryl-1-phenylhydrazines

Synthesis of 1-aryl-1-phenylhydrazines (2) from N-aryl-N- phenylaminophthalimides (1) which were synthesized by the phenylation of 1 with triphenylbismuth and cupric acetate is described.